Point72 Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,471,771
| Closed | -$3.16M | – | 1873 |
|
|
2024
Q3 | $3.16M | Hold |
1,471,771
| – | – | 0.01% | 678 |
|
|
2024
Q2 | $7.59M | Hold |
1,471,771
| – | – | 0.02% | 563 |
|
|
2024
Q1 | $7.87M | Hold |
1,471,771
| – | – | 0.02% | 648 |
|
|
2023
Q4 | $11.5M | Buy |
+1,471,771
| New | +$11.5M | 0.03% | 537 |
|
|
2020
Q4 | – | Sell |
-65,799
| Closed | -$5.82M | – | 1119 |
|
|
2020
Q3 | $5.82M | Sell |
65,799
-87,593
| -57% | -$7.74M | 0.03% | 491 |
|
|
2020
Q2 | $16.4M | Sell |
153,392
-74,108
| -33% | -$7.9M | 0.11% | 237 |
|
|
2020
Q1 | $13.5M | Buy |
+227,500
| New | +$13.5M | 0.11% | 259 |
|
|
2019
Q1 | – | Sell |
-24,000
| Closed | -$1.34M | – | 1155 |
|
|
2018
Q4 | $1.34M | Buy |
24,000
+15,816
| +193% | +$881K | 0.01% | 678 |
|
|
2018
Q3 | $975K | Sell |
8,184
-8,496
| -51% | -$1.01M | ﹤0.01% | 697 |
|
|
2018
Q2 | $1.7M | Buy |
+16,680
| New | +$1.7M | 0.01% | 617 |
|